By my reckoning, IF the CD19/CF33 CAR-T trial should succeed and cure solid tumour, IMU will way surpass CSL. I have posted before the market size of solid tumour can reach up to US$474bn by 2027. If my maths is correct, even just taking 10% of that is about US$50bn/ year. At a PE of just 20 will give IMU a market cap of US$1 trillion dollar.
I know it is mind blowing, but that is the real potential here. But of course, there is a big IF the trial works.
Media Thread, page-1350
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
-0.002(2.90%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.7¢ | $1.445M | 21.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 2363454 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 14705 | 1 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.002 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.7¢ | 9797879 | ||
| Last updated 16.01pm 22/05/2024 ? | |||||
| IMU (ASX) Chart |